CEA Pharm IVS — Credit Rating and Financial Key Figures
CVR number: 38463721
Folevænget 7, 2920 Charlottenlund
Income statement (kDKK)
2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 2.50 | 3.13 | 3.13 | 3.31 |
| EBIT | 2.50 | 3.13 | 3.13 | 3.31 |
| Pre-tax profit | -2.50 | -3.13 | -3.13 | -3.31 |
| Net earnings | -2.50 | -3.13 | -3.13 | -3.31 |
Assets (kDKK)
2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Investments total | ||||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 5.00 | 5.00 | 5.00 | 5.00 |
| Short term receivables total | 5.00 | 5.00 | 5.00 | 5.00 |
| Balance sheet total (assets) | 5.00 | 5.00 | 5.00 | 5.00 |
Equity and liabilities (kDKK)
2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Share capital | 5.00 | 5.00 | 5.00 | 5.00 |
| Retained earnings | -2.50 | -5.63 | -8.75 | |
| Profit of the financial year | -2.50 | -3.13 | -3.13 | -3.31 |
| Shareholders equity total | 2.50 | -0.63 | -3.75 | -7.05 |
| Non-current liabilities total | ||||
| Current owed to group member | 3.13 | 6.25 | 9.55 | |
| Other non-interest bearing current liabilities | 2.50 | 2.50 | 2.50 | 2.50 |
| Current liabilities total | 2.50 | 5.63 | 8.75 | 12.05 |
| Balance sheet total (liabilities) | 5.00 | 5.00 | 5.00 | 5.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.